Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions
- 1 June 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 133 (4) , 539-549
- https://doi.org/10.1038/sj.bjp.0704121
Abstract
Based on an unexpected high maximum response to piperidine‐4‐sulphonic acid (P4S) at human α1α6β2γ2 GABAA receptors expressed in Xenopus oocytes attempts to correlate this finding with the pharmacological profile of P4S and other GABAA receptor ligands in neuronal cultures from rat cerebellar granule cells and rat cerebral cortex were carried out. GABA and isoguvacine acted as full and piperidine‐4‐sulphonic acid (P4S) as partial agonists, respectively, at α1β2γ2, α6β2γ2 and α1α6β2γ2 GABA receptors expressed in Xenopus oocytes with differences in potency. Whole‐cell patch‐clamp recordings were used to investigate the pharmacological profile of the partial GABAA receptor agonists 4,5,6,7‐tetrahydroisoxazolo‐(5,4‐c)pyridin‐3‐ol (THIP), P4S, 5‐(4‐piperidyl)isoxazol‐3‐ol (4‐PIOL), and 3‐(4‐piperidyl)isoxazol‐5‐ol (iso‐4‐PIOL), and the competitive GABAA receptor antagonists Bicuculline Methbromide (BMB) and 2‐(3‐carboxypropyl)‐3‐amino‐6‐methoxyphenyl‐pyridazinium bromide (SR95531) on cerebral cortical and cerebellar granule neurons. In agreement with findings in oocytes, GABA, isoguvacine and P4S showed similar pharmacological profiles in cultured cortical and cerebellar neurones, which are known to express mainly α1, α2, α3, and α5 containing receptors and α1, α6 and α1α6 containing receptors, respectively. 4‐PIOL and iso‐4‐PIOL, which at GABAA receptors expressed in oocytes were weak antagonists, showed cell type dependent potency as inhibitors of GABA mediated responses. Thus, 4‐PIOL was slightly more potent at cortical neurones than at granule neurones and iso‐4‐PIOL was more potent in inhibiting isoguvacine‐evoked currents at cortical than at granule neurons. Furthermore the maximum response to 4‐PIOL corresponded to that of a partial agonist, whereas that of iso‐4‐PIOL gave a maximum response close to zero. It is concluded that the pharmacological profile of partial agonists is highly dependent on the receptor composition, and that small structural changes of a ligand can alter the selectivity towards different subunit compositions. Moreover, this study shows that pharmacological actions determined in oocytes are generally in agreement with data obtained from cultured neurons. British Journal of Pharmacology (2001) 133, 539–549; doi:10.1038/sj.bjp.0704121Keywords
This publication has 47 references indexed in Scilit:
- GABAA receptor subunit interactions important for benzodiazepine and zinc modulation: a patch‐clamp and single cell RT‐PCR studyEuropean Journal of Neuroscience, 2001
- Electrophysiological Evidence for the Coexistence of α1 and α6 Subunits in a Single Functional GABAA ReceptorJournal of Neurochemistry, 2000
- Insensitivity to anaesthetic agents conferred by a class of GABAA receptor subunitNature, 1997
- Which GABAA-receptor subtypes really occur in the brain?Trends in Neurosciences, 1996
- Cloning and characterization of the human GABAA receptor α4 subunit: identification of a unique diazepam-insensitive binding siteEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Partial GABAA Receptor Agonists. Synthesis and in Vitro Pharmacology of a Series of Nonannulated Analogs of 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridin-3-olJournal of Medicinal Chemistry, 1995
- Developmental alteration in GABAA receptor structure and physiological properties in cultured cerebellar granule neuronsNeuron, 1994
- GABAA Receptor ChannelsAnnual Review of Neuroscience, 1994
- Characterization of antagonistic activity and binding properties of SR 95531, a pyridazinl‐GABA derivative, in rat brain and cultured cerebellar neuronal cellsSynapse, 1992
- Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunitFEBS Letters, 1991